PlainPharmaWatch

CMS Open Payments · Program Year 2024

Geistlich Pharma, North America, Inc.

Geistlich Pharma, North America, Inc. reported $401,659.29 in payments to 2,543 physicians and teaching hospitals across 2,560 transactions.

See the rankings → How this is sourced
$401.7K
Total payments
2,560
Transactions
2,543
Recipients
−$254.1K
General Payments vs PY2023

Geistlich Pharma, North America, Inc. reported $401,659.29 in payments to 2,543 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #821 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $157.95 per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Geistlich Pharma, North America, Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#821
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Geistlich Pharma, North America, Inc.'s CMS-reported General Payments decreased by $254.1K (−49.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: GEISTLICH PHARMA, NORTH AMERICA, INC.PY2023: GEISTLICH PHARMA, NORTH AMERICA, INC.PY2024: Geistlich Pharma, North America, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$509.2KPY2024$255.0K
PY2023
$509,160.20
PY2024
$255,020.29

How Geistlich Pharma, North America, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Geistlich Pharma, North America, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$401,659 Top 43% higher than 57% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Geistlich Pharma, North America, Inc.

$401,659.29: that is what Geistlich Pharma, North America, Inc. reported in payments to 2,543 physicians and teaching hospitals during Program Year 2024, spread across 2,560 transactions ($156.90 per transaction, $157.95 per recipient). The company sits at rank #821 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $142.6K, accounting for 35.5% of the company's reported total and 2,442 transactions.

General Payment Breakdown by Type

"Food and Beverage" leads Geistlich Pharma, North America, Inc.'s 4-category general-payment breakdown at $142.6K, 35.5% of the reported total.

How Geistlich Pharma, North America, Inc. divides its payments

How the reported total splits across payment categories

1. Food and Beverage$142.6K2. Travel and Lodging$73.9K3. Honoraria$28.5K4. Consulting Fee$10.0K
Payment Type Amount Transactions
Food and Beverage $142.6K 2,442
Travel and Lodging $73.9K 92
Honoraria $28.5K 8
Consulting Fee $10.0K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $48,489.59 (19.0%) of $255,020.29 in this company's General Payments records across 1,635 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Geistlich Pharma, North America, Inc.

The five named recipients with the highest reported General Payments from this company

Lawrence Didomenico$13.0KDavid Urbanek$12.5KSamar Shaikh$10.3KMichelle Butterworth$6.6KAndrew Read-Fuller$6.1K
  1. 1

    Lawrence Didomenico

    $13,000.00 across 2 reported transactions

  2. 2

    David Urbanek

    $12,473.00 across 33 reported transactions

  3. 3

    Samar Shaikh

    $10,306.90 across 17 reported transactions

  4. 4

    Michelle Butterworth

    $6,621.69 across 2 reported transactions

  5. 5

    Andrew Read-Fuller

    $6,088.00 across 3 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $156.90. Average per recipient: $157.95.

Total Amount

$401,659.29

Avg per Transaction

$156.90

Avg per Recipient

$157.95

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Geistlich Pharma, North America, Inc. Share

0.0%

#821 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Geistlich Pharma, North America, Inc.

Onkos Surgical, Inc.

$402.3K 461 recipients

Agfa HealthCare Corporation

$400.9K 49 recipients

Mizuho America, Inc.

$403.0K 57 recipients

Osseus Fusion Systems, LLC

$399.7K 120 recipients

Nova Eye, Inc.

$404.7K 474 recipients

Amarin Pharma Inc.

$405.1K 300 recipients

Frequently Asked Questions

How much did Geistlich Pharma, North America, Inc. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Geistlich Pharma, North America, Inc., totaling $401,659.29 across 2,560 transactions to physicians and hospitals.
How many physicians received payments from Geistlich Pharma, North America, Inc.? ▾
2,543 physicians and teaching hospitals received payments from Geistlich Pharma, North America, Inc. in 2024, averaging $157.95 per recipient.
What types of payments did Geistlich Pharma, North America, Inc. make? ▾
General payments from Geistlich Pharma, North America, Inc. span 4 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $142.6K, representing 35.5% of the company's reported total.
How does Geistlich Pharma, North America, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Geistlich Pharma, North America, Inc. ranks #821 by total payment amount.
What is the average payment size from Geistlich Pharma, North America, Inc.? ▾
The average transaction from Geistlich Pharma, North America, Inc. was $156.90 in 2024. The company made 2,560 total transactions to 2,543 recipients.
Where does the payment data for Geistlich Pharma, North America, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Geistlich Pharma, North America, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.